...
首页> 外文期刊>Liver international : >Identifying palliative care needs in a Portuguese liver unit
【24h】

Identifying palliative care needs in a Portuguese liver unit

机译:在葡萄牙肝脏单位中识别姑息治疗需求

获取原文
获取原文并翻译 | 示例

摘要

Abstract Background & Aims Chronic liver disease is a major worldwide cause of morbidity and mortality. Palliative care policies are not clearly established in chronic liver disease. The NECPAL CCOMS ‐ ICO ? ( NEC esidades PAL iativas/Palliative Needs) is a tool to identify palliative care needs, including a section for liver disease. Aim: The aim of this study was to identify palliative care needs in liver patients hospitalised in a tertiary referral Liver Unit. Methods Single‐centre prospective observational study. One hundred and twenty patients with cirrhosis were included and NECPAL questionnaire was applied to all patients in a 7‐month period. Results 84.2% of patients were considered as requiring palliative intervention; however, clinicians identified those needs only in 65.8% of the cases and caregivers in 6.7% of the cases; less than 8% of the patients were referred for palliative care consultation. An excessive use of healthcare resources (positive answer to question 3) was strongly associated with a positive need for palliative care (positive NECPAL ): OR 7.305, CI 95% 2.54‐20.995, P ??.001). An excessive use of healthcare facilities has a sensitivity of 84.2% and a specificity of 42.1% for prediction of a positive NECPAL result ( AUC 0.710, 95% CI 0.570‐0.850, P ?=?.004). Conclusions The NECPAL CCOMS ‐ ICO ? represents a feasible and easy‐to‐use tool to identify palliative care needs in patients with chronic liver disease.
机译:抽象背景& AIMS慢性肝病是全球发病率和死亡率的主要原因。在慢性肝病中没有明确建立姑息治疗政策。 Necpal Ccoms - ico? (NEC Esidades Pal Iativas / Palliative需求)是一种识别姑息治疗需求的工具,包括肝病的一部分。目的:本研究的目的是识别在第三节推荐肝单位住院的肝脏患者中的姑息治疗需求。方法单中心前瞻性观测研究。包括肝硬化患者,并在7个月内将NECPAL问卷应用于所有患者。结果84.2%的患者被认为是需要姑息性干预;但是,临床医生只在65.8%的案件和护理人员中确定了这些需求;不到8%的患者被提及姑息治疗咨询。过度使用医疗资源(问题3的肯定答案)与姑息治疗(阳性NECPAL):或7.305,CI 95%2.54-20.995,P≤001)强烈地关联。过度使用医疗保健设施的敏感性为84.2%,特异性为42.1%,用于预测阳性NECPAL结果(AUC 0.710,95%CI 0.570-0.850,P?= 004)。结论NECPAL CCOMS - ICO?代表了可行且易于使用的工具,以识别慢性肝病患者的姑息治疗需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号